ClinicalTrials.govpublic full text
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
head and neck cancer, head and neck, gemcitabine, paclitaxel, radiation, low-dose radiation, recurrent, metastatic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 808116
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.